HEALY JAMES purchased 35.5% of their position (444.44K shares) of ARRIVENT BIOPHARMA, INC. on the open market
Open‑market purchase worth $8.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 1/31/2024ACC: 0001104659-24-008796
+444.44K
Net shares
Net buyer
$8.00M
Total acquired
1
Open market trades
1B · 0S
3
Total transactions
1.70M acquired · 1.25M disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+1.25M
Price / share
—
Trade value
—
% of position
New position
1/30/2024
0.00→1.25M
Common Stock
Indirect
Shares
+444.44K
Price / share
$18.00
Trade value
$8M
% of position
35.5%
1/30/2024
1.25M→1.70M
Total
Net shares
+1.70M
Net value
$8M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/30/2024 | C · Conversion | +1.25M | — | — | New position | 0.00 | 1.25M |
| Common Stock Indirect | 1/30/2024 | P · Purchase | +444.44K | $18.00 | $8M | 35.5% | 1.25M | 1.70M |
| Total | +1.70M | $8M | ||||||
Derivative Transactions1
Series B Preferred Stock
Indirect
Converts to
Common Stock
1.25M shares
Shares
−1.25M
Strike price
Held after
0.00
Exercisable
—
1/30/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Indirect | Common Stock1.25M shares | 1/30/2024 | C · Conversion | −1.25M | — | 0.00 |